What does science tell us about current screening recommendations?

Creating and Sustaining Cancer Movements: An all of society approach to cancer control

Comparing toxicity profiles for 72 hour infusional and conventional bleomycin in testicular cancer

DIfferences in prostate treatment between ROI and Northern Ireland, and measuring patient opinions

HPV prevalence in screened population and types associated with cervix disease

Treatment decision making, screening and palliative care

Combined use of PET and MRI imaging

Choosing the right treatment for each patient: The emergence of personalised healthcare in non-small cell lung cancer

The role of molecular pathways in therapeutic response and outcomes in breast cancer

Addressing the challenges of an aging population

Advances in geriatric, medical oncology

Unravelling the complexity of assessment in older patients